1	3	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Discussion	_	_	NN	_	_	_	_	_


1	While	_	_	IN	_	_	_	_	_
2	most	_	_	JJS	_	_	_	_	_
3	nAChR	_	_	NNP	_	_	_	_	_
4	agonists	_	_	NNS	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	antagonists	_	_	NNS	_	_	_	_	_
7	binding	_	_	VBG	_	_	_	_	_
8	at	_	_	IN	_	_	_	_	_
9	ACh	_	_	NNP	_	_	_	_	_
10	orthosteric	_	_	JJ	_	_	_	_	_
11	sites	_	_	NNS	_	_	_	_	_
12	are	_	_	VBP	_	_	_	_	_
13	basic	_	_	JJ	_	_	_	_	_
14	molecules	_	_	NNS	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	at	_	_	IN	_	_	_	_	_
17	least	_	_	JJS	_	_	_	_	_
18	one	_	_	CD	_	_	_	_	_
19	ionizable	_	_	JJ	_	_	_	_	_
20	N	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	there	_	_	EX	_	_	_	_	_
23	are	_	_	VBP	_	_	_	_	_
24	exceptions	_	_	NNS	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	including	_	_	VBG	_	_	_	_	_
27	lophotoxin	_	_	NN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	neonicotinoids	_	_	NNS	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	some	_	_	DT	_	_	_	_	_
33	recently	_	_	RB	_	_	_	_	_
34	synthesized	_	_	VBN	_	_	_	_	_
35	pyrimidine	_	_	NN	_	_	_	_	_
36	agonists	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	optimize	_	_	VB	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	molecule	_	_	NN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	serve	_	_	VB	_	_	_	_	_
7	as	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	drug	_	_	NN	_	_	_	_	_
10	or	_	_	CC	_	_	_	_	_
11	selective	_	_	JJ	_	_	_	_	_
12	molecular	_	_	JJ	_	_	_	_	_
13	probe	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	some	_	_	DT	_	_	_	_	_
16	receptor	_	_	NN	_	_	_	_	_
17	it	_	_	PRP	_	_	_	_	_
18	is	_	_	VBZ	_	_	_	_	_
19	important	_	_	JJ	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	identify	_	_	VB	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	form	_	_	NN	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	which	_	_	WDT	_	_	_	_	_
26	it	_	_	PRP	_	_	_	_	_
27	interacts	_	_	VBZ	_	_	_	_	_
28	optimally	_	_	RB	_	_	_	_	_
29	with	_	_	IN	_	_	_	_	_
30	its	_	_	PRP$	_	_	_	_	_
31	target	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	case	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	anabaseine	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	our	_	_	PRP$	_	_	_	_	_
8	identification	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	cyclic	_	_	JJ	_	_	_	_	_
12	iminium	_	_	NN	_	_	_	_	_
13	form	_	_	NN	_	_	_	_	_
14	as	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	most	_	_	RBS	_	_	_	_	_
17	active	_	_	JJ	_	_	_	_	_
18	(	_	_	-LRB-	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	possibly	_	_	RB	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	only	_	_	JJ	_	_	_	_	_
23	)	_	_	-RRB-	_	_	_	_	_
24	form	_	_	NN	_	_	_	_	_
25	suggests	_	_	VBZ	_	_	_	_	_
26	that	_	_	IN	_	_	_	_	_
27	structural	_	_	JJ	_	_	_	_	_
28	modifications	_	_	NNS	_	_	_	_	_
29	that	_	_	WDT	_	_	_	_	_
30	enhance	_	_	VBP	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	basicity	_	_	NN	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	its	_	_	PRP$	_	_	_	_	_
35	tetrahydropyridyl	_	_	NN	_	_	_	_	_
36	nitrogen	_	_	NN	_	_	_	_	_
37	will	_	_	MD	_	_	_	_	_
38	enhance	_	_	VB	_	_	_	_	_
39	potency	_	_	NN	_	_	_	_	_
40	and	_	_	CC	_	_	_	_	_
41	possibly	_	_	RB	_	_	_	_	_
42	selectivity	_	_	NN	_	_	_	_	_
43	for	_	_	IN	_	_	_	_	_
44	the	_	_	DT	_	_	_	_	_
45	intended	_	_	VBN	_	_	_	_	_
46	receptor	_	_	NN	_	_	_	_	_
47	target	_	_	NN	_	_	_	_	_
48	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	fact	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	major	_	_	JJ	_	_	_	_	_
6	improvement	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	stability	_	_	NN	_	_	_	_	_
9	occurs	_	_	VBZ	_	_	_	_	_
10	with	_	_	IN	_	_	_	_	_
11	addition	_	_	NN	_	_	_	_	_
12	at	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	3-position	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	tetrahydropyridyl	_	_	NN	_	_	_	_	_
18	ring	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	an	_	_	DT	_	_	_	_	_
21	electron-conjugated	_	_	JJ	_	_	_	_	_
22	system	_	_	NN	_	_	_	_	_
23	containing	_	_	VBG	_	_	_	_	_
24	an	_	_	DT	_	_	_	_	_
25	aromatic	_	_	JJ	_	_	_	_	_
26	ring	_	_	NN	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	as	_	_	IN	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	3-(4-dimethylaminobenzylidene)-anabaseine	_	_	NN	_	_	_	_	_
31	or	_	_	CC	_	_	_	_	_
32	3-(2,4-dimethoxybenzylidene)-anabaseine	_	_	NN	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	also	_	_	RB	_	_	_	_	_
35	called	_	_	VBN	_	_	_	_	_
36	GTS-21	_	_	NNP	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	anabaseine	_	_	NN	_	_	_	_	_
3	derivatives	_	_	NNS	_	_	_	_	_
4	do	_	_	VBP	_	_	_	_	_
5	not	_	_	RB	_	_	_	_	_
6	undergo	_	_	VB	_	_	_	_	_
7	ring	_	_	NN	_	_	_	_	_
8	opening	_	_	NN	_	_	_	_	_
9	(	_	_	-LRB-	_	_	_	_	_
10	hydrolysis	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	imine	_	_	NN	_	_	_	_	_
14	bond	_	_	NN	_	_	_	_	_
15	)	_	_	-RRB-	_	_	_	_	_
16	under	_	_	IN	_	_	_	_	_
17	physiological	_	_	JJ	_	_	_	_	_
18	conditions	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	due	_	_	JJ	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	their	_	_	PRP$	_	_	_	_	_
23	extended	_	_	VBN	_	_	_	_	_
24	π	_	_	NN	_	_	_	_	_
25	electron	_	_	NN	_	_	_	_	_
26	conjugation	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Previously	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	it	_	_	PRP	_	_	_	_	_
4	was	_	_	VBD	_	_	_	_	_
5	assumed	_	_	VBN	_	_	_	_	_
6	(	_	_	-LRB-	_	_	_	_	_
7	but	_	_	CC	_	_	_	_	_
8	not	_	_	RB	_	_	_	_	_
9	experimentally	_	_	RB	_	_	_	_	_
10	tested	_	_	VBN	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	that	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	cyclic	_	_	JJ	_	_	_	_	_
15	iminium	_	_	NN	_	_	_	_	_
16	form	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	anabaseine	_	_	NN	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	one	_	_	CD	_	_	_	_	_
22	which	_	_	WDT	_	_	_	_	_
23	binds	_	_	VBZ	_	_	_	_	_
24	avidly	_	_	RB	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	ACh	_	_	NN	_	_	_	_	_
28	binding	_	_	NN	_	_	_	_	_
29	site	_	_	NN	_	_	_	_	_
30	in	_	_	IN	_	_	_	_	_
31	nAChRs	_	_	NNP	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	form	_	_	NN	_	_	_	_	_
3	was	_	_	VBD	_	_	_	_	_
4	modeled	_	_	VBN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	fit	_	_	VB	_	_	_	_	_
7	into	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	muscle	_	_	NN	_	_	_	_	_
10	type	_	_	NN	_	_	_	_	_
11	homology	_	_	NN	_	_	_	_	_
12	model	_	_	NN	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	crystal	_	_	NN	_	_	_	_	_
3	structure	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	molluscan	_	_	JJ	_	_	_	_	_
7	acetylcholine	_	_	NN	_	_	_	_	_
8	binding	_	_	NN	_	_	_	_	_
9	protein	_	_	NN	_	_	_	_	_
10	binding	_	_	NN	_	_	_	_	_
11	anabaseine	_	_	NN	_	_	_	_	_
12	actually	_	_	RB	_	_	_	_	_
13	was	_	_	VBD	_	_	_	_	_
14	derived	_	_	VBN	_	_	_	_	_
15	from	_	_	IN	_	_	_	_	_
16	crystals	_	_	NNS	_	_	_	_	_
17	containing	_	_	VBG	_	_	_	_	_
18	both	_	_	CC	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	cyclic	_	_	JJ	_	_	_	_	_
21	iminium	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	open-chain	_	_	JJ	_	_	_	_	_
25	monocationic	_	_	JJ	_	_	_	_	_
26	form	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	anabaseine	_	_	NN	_	_	_	_	_
29	occupying	_	_	VBG	_	_	_	_	_
30	some	_	_	DT	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	five	_	_	CD	_	_	_	_	_
34	identical	_	_	JJ	_	_	_	_	_
35	binding	_	_	NN	_	_	_	_	_
36	sites	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	Unlike	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	cyclic	_	_	JJ	_	_	_	_	_
4	iminium	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	ammonium-ketone	_	_	JJ	_	_	_	_	_
8	form	_	_	NN	_	_	_	_	_
9	ammonium	_	_	NN	_	_	_	_	_
10	group	_	_	NN	_	_	_	_	_
11	did	_	_	VBD	_	_	_	_	_
12	not	_	_	RB	_	_	_	_	_
13	insert	_	_	VB	_	_	_	_	_
14	into	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	“	_	_	``	_	_	_	_	_
17	aromatic	_	_	JJ	_	_	_	_	_
18	box	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_
20	”	_	_	''	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	preparation	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	AChBP-anabaseine	_	_	JJ	_	_	_	_	_
7	crystals	_	_	NNS	_	_	_	_	_
8	very	_	_	RB	_	_	_	_	_
9	high	_	_	JJ	_	_	_	_	_
10	anabaseine	_	_	NN	_	_	_	_	_
11	concentrations	_	_	NNS	_	_	_	_	_
12	were	_	_	VBD	_	_	_	_	_
13	used	_	_	VBN	_	_	_	_	_
14	so	_	_	IN	_	_	_	_	_
15	that	_	_	IN	_	_	_	_	_
16	most	_	_	JJS	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	five	_	_	CD	_	_	_	_	_
20	sites	_	_	NNS	_	_	_	_	_
21	would	_	_	MD	_	_	_	_	_
22	be	_	_	VB	_	_	_	_	_
23	occupied	_	_	VBN	_	_	_	_	_
24	;	_	_	:	_	_	_	_	_
25	therefore	_	_	RB	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	presence	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	ammonium-ketone	_	_	JJ	_	_	_	_	_
31	form	_	_	NN	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	crystal	_	_	NN	_	_	_	_	_
35	structure	_	_	NN	_	_	_	_	_
36	does	_	_	VBZ	_	_	_	_	_
37	not	_	_	RB	_	_	_	_	_
38	necessarily	_	_	RB	_	_	_	_	_
39	indicate	_	_	VB	_	_	_	_	_
40	that	_	_	IN	_	_	_	_	_
41	this	_	_	DT	_	_	_	_	_
42	form	_	_	NN	_	_	_	_	_
43	of	_	_	IN	_	_	_	_	_
44	anabaseine	_	_	NN	_	_	_	_	_
45	would	_	_	MD	_	_	_	_	_
46	bind	_	_	VB	_	_	_	_	_
47	to	_	_	TO	_	_	_	_	_
48	AChBPs	_	_	NNS	_	_	_	_	_
49	and	_	_	CC	_	_	_	_	_
50	nAChRs	_	_	NNS	_	_	_	_	_
51	at	_	_	IN	_	_	_	_	_
52	the	_	_	DT	_	_	_	_	_
53	low	_	_	JJ	_	_	_	_	_
54	concentrations	_	_	NNS	_	_	_	_	_
55	of	_	_	IN	_	_	_	_	_
56	anabaseine	_	_	NN	_	_	_	_	_
57	that	_	_	WDT	_	_	_	_	_
58	occur	_	_	VBP	_	_	_	_	_
59	in	_	_	IN	_	_	_	_	_
60	our	_	_	PRP$	_	_	_	_	_
61	in	_	_	IN	_	_	_	_	_
62	vitro	_	_	NN	_	_	_	_	_
63	functional	_	_	JJ	_	_	_	_	_
64	and	_	_	CC	_	_	_	_	_
65	binding	_	_	JJ	_	_	_	_	_
66	studies	_	_	NNS	_	_	_	_	_
67	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	ability	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	variety	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	2-(aryl)-1,4,5,6-tetrahydropyrmidines	_	_	NNS	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	block	_	_	VB	_	_	_	_	_
10	neuromuscular	_	_	JJ	_	_	_	_	_
11	nAChRs	_	_	NNS	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	produce	_	_	VB	_	_	_	_	_
14	teratogenic	_	_	JJ	_	_	_	_	_
15	effects	_	_	NNS	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	chick	_	_	NN	_	_	_	_	_
18	embryos	_	_	NNS	_	_	_	_	_
19	was	_	_	VBD	_	_	_	_	_
20	reported	_	_	VBN	_	_	_	_	_
21	long	_	_	RB	_	_	_	_	_
22	ago	_	_	RB	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Some	_	_	DT	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	these	_	_	DT	_	_	_	_	_
4	compounds	_	_	NNS	_	_	_	_	_
5	were	_	_	VBD	_	_	_	_	_
6	reported	_	_	VBN	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	be	_	_	VB	_	_	_	_	_
9	nAChR	_	_	NN	_	_	_	_	_
10	agonists	_	_	NNS	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	only	_	_	JJ	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	PTHP	_	_	NNP	_	_	_	_	_
6	on	_	_	IN	_	_	_	_	_
7	neurons	_	_	NNS	_	_	_	_	_
8	was	_	_	VBD	_	_	_	_	_
9	that	_	_	DT	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	Upshall	_	_	NNP	_	_	_	_	_
12	et	_	_	FW	_	_	_	_	_
13	al.	_	_	FW	_	_	_	_	_
14	on	_	_	IN	_	_	_	_	_
15	leech	_	_	NN	_	_	_	_	_
16	Retzius	_	_	NNP	_	_	_	_	_
17	cells	_	_	NNS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Our	_	_	PRP$	_	_	_	_	_
2	results	_	_	NNS	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	indicate	_	_	VBP	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	PTHP	_	_	NNP	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	potent	_	_	JJ	_	_	_	_	_
10	agonist	_	_	NN	_	_	_	_	_
11	at	_	_	IN	_	_	_	_	_
12	neuronal	_	_	JJ	_	_	_	_	_
13	as	_	_	RB	_	_	_	_	_
14	well	_	_	RB	_	_	_	_	_
15	as	_	_	IN	_	_	_	_	_
16	neuromuscular	_	_	JJ	_	_	_	_	_
17	nAChRs	_	_	NNPS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	2-aryl	_	_	JJ	_	_	_	_	_
3	compounds	_	_	NNS	_	_	_	_	_
4	reported	_	_	VBD	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	Brimblecombe	_	_	NNP	_	_	_	_	_
8	et	_	_	FW	_	_	_	_	_
9	al.	_	_	FW	_	_	_	_	_
10	study	_	_	NN	_	_	_	_	_
11	did	_	_	VBD	_	_	_	_	_
12	not	_	_	RB	_	_	_	_	_
13	include	_	_	VB	_	_	_	_	_
14	PTHP	_	_	NN	_	_	_	_	_
15	or	_	_	CC	_	_	_	_	_
16	other	_	_	JJ	_	_	_	_	_
17	compounds	_	_	NNS	_	_	_	_	_
18	having	_	_	VBG	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	2-(3-pyridyl)-	_	_	CD	_	_	_	_	_
21	substituent	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	which	_	_	WDT	_	_	_	_	_
24	is	_	_	VBZ	_	_	_	_	_
25	known	_	_	VBN	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	be	_	_	VB	_	_	_	_	_
28	essential	_	_	JJ	_	_	_	_	_
29	for	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	agonist	_	_	NN	_	_	_	_	_
32	activity	_	_	NN	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	nicotine	_	_	NN	_	_	_	_	_
35	and	_	_	CC	_	_	_	_	_
36	of	_	_	IN	_	_	_	_	_
37	anabaseine	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	PTHP	_	_	NN	_	_	_	_	_
3	to	_	_	TO	_	_	_	_	_
4	be	_	_	VB	_	_	_	_	_
5	equipotent	_	_	JJ	_	_	_	_	_
6	with	_	_	IN	_	_	_	_	_
7	anabaseine	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	based	_	_	VBN	_	_	_	_	_
10	on	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	I+	_	_	NNP	_	_	_	_	_
13	form	_	_	NN	_	_	_	_	_
14	being	_	_	VBG	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	only	_	_	RB	_	_	_	_	_
17	active	_	_	JJ	_	_	_	_	_
18	form	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	its	_	_	PRP$	_	_	_	_	_
21	EC50	_	_	NNP	_	_	_	_	_
22	would	_	_	MD	_	_	_	_	_
23	need	_	_	VB	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	be	_	_	VB	_	_	_	_	_
26	~1/3	_	_	CD	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	EC50	_	_	NN	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	anabaseine	_	_	NN	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	since	_	_	IN	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	anabaseine	_	_	NN	_	_	_	_	_
36	(	_	_	-LRB-	_	_	_	_	_
37	I+	_	_	NN	_	_	_	_	_
38	)	_	_	-RRB-	_	_	_	_	_
39	is	_	_	VBZ	_	_	_	_	_
40	~1/3	_	_	CD	_	_	_	_	_
41	of	_	_	IN	_	_	_	_	_
42	its	_	_	PRP$	_	_	_	_	_
43	total	_	_	JJ	_	_	_	_	_
44	concentration	_	_	NN	_	_	_	_	_
45	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	data	_	_	NNS	_	_	_	_	_
3	for	_	_	IN	_	_	_	_	_
4	PTHP	_	_	NNP	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	anabaseine	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	Figure	_	_	NNP	_	_	_	_	_
9	3	_	_	CD	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	Figure	_	_	NN	_	_	_	_	_
12	4	_	_	CD	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	Table	_	_	NNP	_	_	_	_	_
16	1	_	_	CD	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	indicate	_	_	VBP	_	_	_	_	_
19	that	_	_	IN	_	_	_	_	_
20	PTHP	_	_	NNP	_	_	_	_	_
21	has	_	_	VBZ	_	_	_	_	_
22	approximately	_	_	RB	_	_	_	_	_
23	30	_	_	CD	_	_	_	_	_
24	%	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	potency	_	_	NN	_	_	_	_	_
28	predicted	_	_	VBN	_	_	_	_	_
29	for	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	anabaseine	_	_	NN	_	_	_	_	_
32	cyclic	_	_	JJ	_	_	_	_	_
33	iminium	_	_	NN	_	_	_	_	_
34	form	_	_	NN	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	One	_	_	CD	_	_	_	_	_
2	possible	_	_	JJ	_	_	_	_	_
3	explanation	_	_	NN	_	_	_	_	_
4	for	_	_	IN	_	_	_	_	_
5	this	_	_	DT	_	_	_	_	_
6	slightly	_	_	RB	_	_	_	_	_
7	inferior	_	_	JJ	_	_	_	_	_
8	potency	_	_	NN	_	_	_	_	_
9	is	_	_	VBZ	_	_	_	_	_
10	that	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	additional	_	_	JJ	_	_	_	_	_
13	N	_	_	NN	_	_	_	_	_
14	on	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	tetrahydropyrmidinyl	_	_	JJ	_	_	_	_	_
17	ring	_	_	NN	_	_	_	_	_
18	must	_	_	MD	_	_	_	_	_
19	form	_	_	VB	_	_	_	_	_
20	an	_	_	DT	_	_	_	_	_
21	H	_	_	NN	_	_	_	_	_
22	bond	_	_	NN	_	_	_	_	_
23	with	_	_	IN	_	_	_	_	_
24	some	_	_	DT	_	_	_	_	_
25	other	_	_	JJ	_	_	_	_	_
26	atom	_	_	NN	_	_	_	_	_
27	within	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	aromatic	_	_	JJ	_	_	_	_	_
30	box	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	nAChR	_	_	NNP	_	_	_	_	_
34	orthosteric	_	_	JJ	_	_	_	_	_
35	binding	_	_	NN	_	_	_	_	_
36	site	_	_	NN	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	this	_	_	DT	_	_	_	_	_
39	may	_	_	MD	_	_	_	_	_
40	be	_	_	VB	_	_	_	_	_
41	energetically	_	_	RB	_	_	_	_	_
42	unfavorable	_	_	JJ	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	While	_	_	IN	_	_	_	_	_
2	2,3′-bipyridyl	_	_	NNP	_	_	_	_	_
3	displayed	_	_	VBD	_	_	_	_	_
4	only	_	_	RB	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	marginal	_	_	JJ	_	_	_	_	_
7	potency	_	_	NN	_	_	_	_	_
8	at	_	_	IN	_	_	_	_	_
9	vertebrate	_	_	JJ	_	_	_	_	_
10	receptors	_	_	NNS	_	_	_	_	_
11	that	_	_	WDT	_	_	_	_	_
12	could	_	_	MD	_	_	_	_	_
13	be	_	_	VB	_	_	_	_	_
14	predicted	_	_	VBN	_	_	_	_	_
15	from	_	_	IN	_	_	_	_	_
16	its	_	_	PRP$	_	_	_	_	_
17	pKa	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	it	_	_	PRP	_	_	_	_	_
20	has	_	_	VBZ	_	_	_	_	_
21	been	_	_	VBN	_	_	_	_	_
22	found	_	_	VBN	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	be	_	_	VB	_	_	_	_	_
25	quite	_	_	RB	_	_	_	_	_
26	paralytic	_	_	JJ	_	_	_	_	_
27	to	_	_	TO	_	_	_	_	_
28	insects	_	_	NNS	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	crustaceans	_	_	NNS	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	At	_	_	IN	_	_	_	_	_
2	least	_	_	JJS	_	_	_	_	_
3	some	_	_	DT	_	_	_	_	_
4	arthropod	_	_	NN	_	_	_	_	_
5	nAChRs	_	_	NNS	_	_	_	_	_
6	are	_	_	VBP	_	_	_	_	_
7	known	_	_	VBN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	not	_	_	RB	_	_	_	_	_
10	require	_	_	VB	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	cationic	_	_	JJ	_	_	_	_	_
13	ligand	_	_	NN	_	_	_	_	_
14	for	_	_	IN	_	_	_	_	_
15	activation	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	shown	_	_	VBN	_	_	_	_	_
19	by	_	_	IN	_	_	_	_	_
20	many	_	_	JJ	_	_	_	_	_
21	studies	_	_	NNS	_	_	_	_	_
22	with	_	_	IN	_	_	_	_	_
23	neonicotinoid	_	_	JJ	_	_	_	_	_
24	insecticides	_	_	NNS	_	_	_	_	_
25	such	_	_	JJ	_	_	_	_	_
26	as	_	_	IN	_	_	_	_	_
27	imidachloprid	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	neonicotinoids	_	_	NNS	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	display	_	_	VBP	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	limited	_	_	JJ	_	_	_	_	_
7	activity	_	_	NN	_	_	_	_	_
8	at	_	_	IN	_	_	_	_	_
9	vertebrate	_	_	NN	_	_	_	_	_
10	nAChRs	_	_	NNP	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	seems	_	_	VBZ	_	_	_	_	_
3	likely	_	_	JJ	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	2,3′-bipyridyl	_	_	NNP	_	_	_	_	_
6	affects	_	_	VBZ	_	_	_	_	_
7	some	_	_	DT	_	_	_	_	_
8	arthropod	_	_	NN	_	_	_	_	_
9	nAChRs	_	_	NNS	_	_	_	_	_
10	through	_	_	IN	_	_	_	_	_
11	its	_	_	PRP$	_	_	_	_	_
12	unionized	_	_	JJ	_	_	_	_	_
13	form	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	One	_	_	CD	_	_	_	_	_
2	can	_	_	MD	_	_	_	_	_
3	speculate	_	_	VB	_	_	_	_	_
4	as	_	_	IN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	what	_	_	WP	_	_	_	_	_
7	advantage(s)	_	_	NN	_	_	_	_	_
8	might	_	_	MD	_	_	_	_	_
9	accrue	_	_	VB	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	an	_	_	DT	_	_	_	_	_
12	organism	_	_	NN	_	_	_	_	_
13	(	_	_	-LRB-	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	this	_	_	DT	_	_	_	_	_
16	case	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	hoplonemertine	_	_	NN	_	_	_	_	_
20	or	_	_	CC	_	_	_	_	_
21	ant	_	_	NN	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	produce	_	_	VB	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	secrete	_	_	VB	_	_	_	_	_
27	an	_	_	DT	_	_	_	_	_
28	imine-bond	_	_	NN	_	_	_	_	_
29	containing	_	_	VBG	_	_	_	_	_
30	toxin	_	_	NN	_	_	_	_	_
31	like	_	_	IN	_	_	_	_	_
32	anabaseine	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	entire	_	_	JJ	_	_	_	_	_
3	body	_	_	NN	_	_	_	_	_
4	wall	_	_	NN	_	_	_	_	_
5	integument	_	_	NN	_	_	_	_	_
6	as	_	_	RB	_	_	_	_	_
7	well	_	_	RB	_	_	_	_	_
8	as	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	contiguous	_	_	JJ	_	_	_	_	_
11	epithelium	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	anterior	_	_	JJ	_	_	_	_	_
15	proboscis	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	P.	_	_	FW	_	_	_	_	_
18	peregrina	_	_	FW	_	_	_	_	_
19	contains	_	_	VBZ	_	_	_	_	_
20	very	_	_	RB	_	_	_	_	_
21	high	_	_	JJ	_	_	_	_	_
22	concentrations	_	_	NNS	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	anabaseine	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	proboscis	_	_	NN	_	_	_	_	_
3	everts	_	_	VBZ	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	wraps	_	_	VBZ	_	_	_	_	_
6	around	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	prey	_	_	NN	_	_	_	_	_
9	during	_	_	IN	_	_	_	_	_
10	its	_	_	PRP$	_	_	_	_	_
11	capture	_	_	NN	_	_	_	_	_
12	allowing	_	_	VBG	_	_	_	_	_
13	extensive	_	_	JJ	_	_	_	_	_
14	contact	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	this	_	_	DT	_	_	_	_	_
17	epithelium	_	_	NN	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	its	_	_	PRP$	_	_	_	_	_
20	annelid	_	_	JJ	_	_	_	_	_
21	prey	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	mineralized	_	_	VBN	_	_	_	_	_
3	stylet	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	proboscis	_	_	NN	_	_	_	_	_
7	can	_	_	MD	_	_	_	_	_
8	be	_	_	VB	_	_	_	_	_
9	observed	_	_	VBN	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	produce	_	_	VB	_	_	_	_	_
12	multiple	_	_	JJ	_	_	_	_	_
13	punctures	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	prey	_	_	NN	_	_	_	_	_
17	integument	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	which	_	_	WDT	_	_	_	_	_
20	should	_	_	MD	_	_	_	_	_
21	further	_	_	RB	_	_	_	_	_
22	facilitate	_	_	VB	_	_	_	_	_
23	envenomation	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	potential	_	_	JJ	_	_	_	_	_
5	predators	_	_	NNS	_	_	_	_	_
6	will	_	_	MD	_	_	_	_	_
7	also	_	_	RB	_	_	_	_	_
8	be	_	_	VB	_	_	_	_	_
9	exposed	_	_	VBN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	these	_	_	DT	_	_	_	_	_
12	ways	_	_	NNS	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	anabaseine	_	_	NN	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	related	_	_	JJ	_	_	_	_	_
17	alkaloids	_	_	NNS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Perhaps	_	_	RB	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	major	_	_	JJ	_	_	_	_	_
4	advantage	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	possessing	_	_	VBG	_	_	_	_	_
7	an	_	_	DT	_	_	_	_	_
8	imine	_	_	NN	_	_	_	_	_
9	bond	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	besides	_	_	IN	_	_	_	_	_
12	an	_	_	DT	_	_	_	_	_
13	enhanced	_	_	VBN	_	_	_	_	_
14	affinity	_	_	NN	_	_	_	_	_
15	for	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	nAChR	_	_	NNP	_	_	_	_	_
18	orthosteric	_	_	JJ	_	_	_	_	_
19	site	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	is	_	_	VBZ	_	_	_	_	_
22	its	_	_	PRP$	_	_	_	_	_
23	low	_	_	JJ	_	_	_	_	_
24	basicity	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	which	_	_	WDT	_	_	_	_	_
27	allows	_	_	VBZ	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	unionized	_	_	JJ	_	_	_	_	_
30	form	_	_	NN	_	_	_	_	_
31	to	_	_	TO	_	_	_	_	_
32	reach	_	_	VB	_	_	_	_	_
33	a	_	_	DT	_	_	_	_	_
34	relatively	_	_	RB	_	_	_	_	_
35	high	_	_	JJ	_	_	_	_	_
36	concentration	_	_	NN	_	_	_	_	_
37	in	_	_	IN	_	_	_	_	_
38	the	_	_	DT	_	_	_	_	_
39	neutral	_	_	JJ	_	_	_	_	_
40	pH	_	_	NN	_	_	_	_	_
41	range	_	_	NN	_	_	_	_	_
42	of	_	_	IN	_	_	_	_	_
43	the	_	_	DT	_	_	_	_	_
44	marine	_	_	JJ	_	_	_	_	_
45	environment	_	_	NN	_	_	_	_	_
46	and	_	_	CC	_	_	_	_	_
47	thereby	_	_	RB	_	_	_	_	_
48	enhance	_	_	VB	_	_	_	_	_
49	passive	_	_	JJ	_	_	_	_	_
50	diffusion	_	_	NN	_	_	_	_	_
51	across	_	_	IN	_	_	_	_	_
52	the	_	_	DT	_	_	_	_	_
53	integument	_	_	NN	_	_	_	_	_
54	of	_	_	IN	_	_	_	_	_
55	the	_	_	DT	_	_	_	_	_
56	prey	_	_	NN	_	_	_	_	_
57	or	_	_	CC	_	_	_	_	_
58	predator	_	_	NN	_	_	_	_	_
59	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	integument	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	marine	_	_	JJ	_	_	_	_	_
6	organism	_	_	NN	_	_	_	_	_
7	exposed	_	_	VBN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	sea	_	_	NN	_	_	_	_	_
10	water	_	_	NN	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	likely	_	_	JJ	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	have	_	_	VB	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	pH	_	_	NN	_	_	_	_	_
17	near	_	_	IN	_	_	_	_	_
18	8	_	_	CD	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	well	_	_	RB	_	_	_	_	_
21	above	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	pH	_	_	NN	_	_	_	_	_
24	range	_	_	NN	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	which	_	_	WDT	_	_	_	_	_
27	anabaseine	_	_	NN	_	_	_	_	_
28	is	_	_	VBZ	_	_	_	_	_
29	primarily	_	_	RB	_	_	_	_	_
30	ionized	_	_	VBN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Thus	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	toxin	_	_	NN	_	_	_	_	_
5	has	_	_	VBZ	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	much	_	_	RB	_	_	_	_	_
8	better	_	_	JJR	_	_	_	_	_
9	chance	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	entering	_	_	VBG	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	prey/predator	_	_	NN	_	_	_	_	_
14	than	_	_	IN	_	_	_	_	_
15	would	_	_	MD	_	_	_	_	_
16	anabaseine	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	more	_	_	RBR	_	_	_	_	_
20	basic	_	_	JJ	_	_	_	_	_
21	secondary	_	_	JJ	_	_	_	_	_
22	amine	_	_	NN	_	_	_	_	_
23	analog	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	anabaseine	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_

